• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载纳米弹性脂质体的葡萄糖酸锑钠和酮康唑作为多药载体:一种治疗皮肤利什曼病的新方法。

Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis.

机构信息

Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.

Department of Pathology, Ohio State University Medical Center, Columbus, Ohio 43201, USA.

出版信息

Eur J Pharm Sci. 2020 Mar 30;145:105256. doi: 10.1016/j.ejps.2020.105256. Epub 2020 Feb 4.

DOI:10.1016/j.ejps.2020.105256
PMID:32032778
Abstract

The present study evaluates the efficacy of sodium stibogluconate (SSG) co-loaded with ketoconazole (KTZ) in nano-elastic liposomes (NELs) for the topical treatment of cutaneous leishmaniasis (CL). SSG-KTZ co-loaded NELs were developed and assessed for various physicochemical properties and anti-leishmanial potential. The optimized nano-vesicles have an average size of 212.8 ± 3.1 nm and entrapment efficiency of 61.2 ± 2.9%. SSG-KTZ co-loaded NELs displayed 5.37-fold higher skin permeation of SSG as compared to drug solution. SSG and KTZ displayed a synergistic interaction and flow cytometry revealed enhanced killing of DsRed Leishmania mexicana in infected macrophages. In-vitro and in-vivo anti-leishmanial studies indicated a 10.67-fold lower IC value and a 35.33-fold reduced parasitic burden as compared with plain SSG solution, respectively. SSG-KTZ co-loaded NELs were found to be a promising approach for the topical treatment of CL.

摘要

本研究评估了载酮康唑(KTZ)的葡甲酸钠(SSG)纳米弹性脂质体(NEL)在治疗皮肤利什曼病(CL)中的疗效。制备并评估了 SSG-KTZ 载药 NEL 的各种理化性质和抗利什曼原虫效果。优化后的纳米囊泡平均粒径为 212.8±3.1nm,包封率为 61.2±2.9%。与药物溶液相比,SSG-KTZ 载药 NEL 使 SSG 的皮肤渗透增加了 5.37 倍。SSG 和 KTZ 表现出协同作用,流式细胞术显示,载药 NEL 增强了对感染巨噬细胞中 DsRed 墨西哥利什曼原虫的杀伤作用。体外和体内抗利什曼原虫研究表明,与普通 SSG 溶液相比,IC 值降低了 10.67 倍,寄生虫载量降低了 35.33 倍。SSG-KTZ 载药 NEL 有望成为治疗 CL 的一种新的局部给药方法。

相似文献

1
Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis.载纳米弹性脂质体的葡萄糖酸锑钠和酮康唑作为多药载体:一种治疗皮肤利什曼病的新方法。
Eur J Pharm Sci. 2020 Mar 30;145:105256. doi: 10.1016/j.ejps.2020.105256. Epub 2020 Feb 4.
2
Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.载纳米变形脂质体的葡萄糖酸锑钠用于治疗利什曼病的局部治疗:巨噬细胞作为靶细胞。
Drug Deliv. 2018 Nov;25(1):1595-1606. doi: 10.1080/10717544.2018.1494222.
3
Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.新型米替福新-多酚共载第二代纳米转体的研制与评价及其在皮肤利什曼病中的局部治疗。
Expert Opin Drug Deliv. 2020 Jan;17(1):97-110. doi: 10.1080/17425247.2020.1700227. Epub 2019 Dec 6.
4
Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.局部皮肤利什曼病单独使用或联合肌内注射葡萄糖酸锑钠或口服酮康唑治疗的比较研究。
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):335-40. doi: 10.1111/j.1468-3083.2009.03417.x. Epub 2009 Sep 10.
5
Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.新型两性霉素 B-米替福新共包封第二代超变形脂质体局部治疗皮肤利什曼病。
Int J Pharm. 2020 Jan 5;573:118900. doi: 10.1016/j.ijpharm.2019.118900. Epub 2019 Nov 22.
6
The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.用葡萄糖酸锑钠的非离子表面活性剂囊泡制剂治疗BALB/c小鼠内脏利什曼病所获得的治愈免疫表型不能预防再次感染。
Clin Diagn Lab Immunol. 1999 Jan;6(1):61-5. doi: 10.1128/CDLI.6.1.61-65.1999.
7
Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.短程(每周两次)病灶内注射葡萄糖酸锑钠治疗印度皮肤利什曼病的疗效。
Br J Dermatol. 2010 Oct;163(4):854-8. doi: 10.1111/j.1365-2133.2010.09865.x.
8
Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.阳离子脂质体葡萄糖酸锑钠(SSG),一种用于治疗对SSG敏感和耐药的杜氏利什曼原虫感染的有效治疗工具。
Antimicrob Agents Chemother. 2015 Jan;59(1):344-55. doi: 10.1128/AAC.03305-14. Epub 2014 Nov 3.
9
Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.在危地马拉进行的葡萄糖酸锑钠(喷他脒)与酮康唑治疗皮肤利什曼病的安慰剂对照临床试验。
J Infect Dis. 1992 Mar;165(3):528-34. doi: 10.1093/infdis/165.3.528.
10
Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations.用游离和囊泡型葡萄糖酸锑钠制剂治疗后,杜氏利什曼原虫感染的BALB/c小鼠的免疫反应
Int J Immunopharmacol. 1997 Apr;19(4):195-203. doi: 10.1016/s0192-0561(97)00009-x.

引用本文的文献

1
HSPiP and QbD oriented optimized stearylamine-elastic liposomes for topical delivery of ketoconazole to treat deep seated fungal infections: In vitro and ex vivo evaluations.以HSPiP和质量源于设计理念为导向的优化硬脂胺弹性脂质体用于酮康唑的局部给药以治疗深部真菌感染:体外和离体评价
Int J Pharm X. 2024 Aug 26;8:100279. doi: 10.1016/j.ijpx.2024.100279. eCollection 2024 Dec.
2
Recent Advances in Phytochemical-Based Topical Applications for the Management of Eczema: A Review.基于植物化学的湿疹局部治疗应用的最新进展:综述。
Int J Mol Sci. 2024 May 15;25(10):5375. doi: 10.3390/ijms25105375.
3
Elastic Liposomes Containing Calcium/Magnesium Ferrite Nanoparticles Coupled with Gold Nanorods for Application in Photothermal Therapy.
含有钙/镁铁氧体纳米颗粒与金纳米棒耦合的弹性脂质体在光热疗法中的应用
Nanomaterials (Basel). 2024 Apr 15;14(8):679. doi: 10.3390/nano14080679.
4
Co-Encapsulation of Drugs for Topical Application-A Review.药物经皮给药的共包封-综述。
Molecules. 2023 Feb 2;28(3):1449. doi: 10.3390/molecules28031449.
5
Liposomal drug delivery systems for the treatment of leishmaniasis.用于治疗利什曼病的脂质体药物传递系统。
Parasitol Res. 2022 Nov;121(11):3073-3082. doi: 10.1007/s00436-022-07659-5. Epub 2022 Sep 16.
6
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice.咪喹莫特乳膏皮肤毒性的削减:咪喹莫特纳米转醇质体凝胶与 5%市售乳膏在 BALB/c 小鼠的比较皮肤毒性分析。
Sci Rep. 2022 Aug 20;12(1):14244. doi: 10.1038/s41598-022-18671-1.
7
Application and Efficacy of Melatonin Elastic Liposomes in Photoaging Mice.褪黑素弹性脂质体在光老化小鼠中的应用及疗效
Oxid Med Cell Longev. 2022 Mar 8;2022:7135125. doi: 10.1155/2022/7135125. eCollection 2022.
8
Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.基于纳米技术的抗利什曼病解决方案:深入了解。
J Nanobiotechnology. 2021 Apr 15;19(1):106. doi: 10.1186/s12951-021-00853-0.
9
Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.皮肤利什曼病的局部治疗的治疗进展:综述。
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.
10
Development, Characterization and Use of Liposomes as Amphipathic Transporters of Bioactive Compounds for Melanoma Treatment and Reduction of Skin Inflammation: A Review.发展、表征和利用脂质体作为亲脂性生物活性化合物载体用于治疗黑色素瘤和减轻皮肤炎症:综述。
Int J Nanomedicine. 2020 Oct 8;15:7627-7650. doi: 10.2147/IJN.S263516. eCollection 2020.